Quantcast

Latest Metered-dose inhaler Stories

2010-05-17 08:00:00

REDWOOD CITY, Calif., May 17 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, has been named a TiE50 Winner in the BioSciences category, as a leader in innovation, ingenuity and management excellence. The award was presented to Pearl during TiEcon 2010, an annual convention hosted by The Indus Entrepreneurs (TiE), an organization dedicated to...

2010-05-05 07:00:00

REDWOOD CITY, Calif., May 5 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced four upcoming poster presentations at the Annual Meeting of the American Thoracic Society (ATS) to be held at the Ernest N. Morial Convention Center in New Orleans from May 14-19, 2010. Results from Pearl's Phase 1 safety and pharmacokinetics study of...

2010-04-15 08:30:00

ST. PAUL, Minn., April 15 /PRNewswire-Asia/ -- 3M Drug Delivery Systems recently advanced its participation in the Asian market with a sponsorship of the Asia Pharma R&D Leaders 2010 event, held March 4 and 5 in Shanghai, China. The event, organized by Global Leaders Institute, the leading life science event producer in China, brings together leading pharmaceutical industry professionals, policymakers, and academics to discuss Asia's role in the manufacturing, research and development...

2010-04-13 17:12:00

RIDGEFIELD, Conn., April 13 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD)...

2010-04-13 12:59:00

SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move...

2010-04-13 12:49:00

SILVER SPRING, Md., April 13 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) says that seven metered dose inhalers that contain chlorofluorocarbons (CFCs) are being phased out in the United States. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) These inhalers use CFCs as propellants to spray the medicine out of the inhaler so patients can breathe the medicine into their lungs. They're used for the treatment of asthma or chronic obstructive pulmonary...

2010-03-18 10:11:00

PITTSBURGH, March 18 /PRNewswire/ -- ChemImage, a world leader in chemical imaging products and services, will present the results of an ingredient-specific particle sizing (ISPST) study on a combination Metered Dose Inhaler product at Respiratory Drug Delivery (RDD) 2010 (www.rddonline.com). This conference will take place from April 25th - 29th in Orlando, Florida and will feature thought leaders discussing current biological and pharmaceutical issues related to nasal and respiratory...

2010-03-01 09:00:00

MIDLOTHIAN, Va., March 1 /PRNewswire/ -- Today, PARI Respiratory Equipment launched their newest aerosol delivery system, the Vios. Paired with PARI's gold standard reusable nebulizers, Vios delivers fast treatments, small particle size, and high respirable drug dose to the lungs. Vios also features an extended warranty and Timestrip, an easy to use reminder for patients to replace their nebulizer every six months. "We are excited for physicians treating respiratory diseases to begin...

2010-02-26 07:11:00

HORSHAM, Pa., Feb. 26 /PRNewswire-FirstCall/ -- Increasing evidence supports the importance of small airways in the diagnosis and treatment of asthma; however, focused areas of discussion and critical review of this topic have been lacking. To foster a better understanding of the role of small airways in asthma management, Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), will be providing reprints of a special supplement entitled "Small Airway...

2010-02-25 05:18:00

GAINESVILLE, Fla., Feb. 25 /PRNewswire/ -- Exponential growth is the term that some electronic cigarette retailers are using to express the increase in sales volume that they are experiencing over the last 6 to 12 months and this growth is continuing despite the corporate sponsored anti-smoking campaign against them. The public has judged the information and test results that have been done on both sides of the arena and seem to be listening to the electronic cigarette side with more...


Latest Metered-dose inhaler Reference Libraries

Nicotine Replacement Therapy
2013-03-04 16:06:28

Nicotine replacement therapy is the administration of nicotine by other means than smoking. This change in the way nicotine is delivered prevents the harmful effects of smoking and is usually used in smoking cessation. Types Nicotine replacement therapy can be administered in several forms. The type used depends on the patient and what fits into their lifestyle best. The forms available include: Nicotine patches – transdermal (through the skin) Nicotine gum – orally (through the...

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.